A detailed history of Teza Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Teza Capital Management LLC holds 5,040 shares of LLY stock, worth $3.87 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
5,040
Previous 4,697 7.3%
Holding current value
$3.87 Million
Previous $4.25 Million 5.01%
% of portfolio
0.49%
Previous 0.53%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $264,844 - $329,286
343 Added 7.3%
5,040 $4.47 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3.4 Million - $4.27 Million
4,697 New
4,697 $4.25 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.08 Million - $1.27 Million
-2,047 Reduced 25.49%
5,983 $3.49 Million
Q3 2023

Feb 22, 2024

BUY
$434.7 - $599.3 $1.51 Million - $2.08 Million
3,467 Added 328.0%
4,524 $2.43 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $3.49 Million - $4.81 Million
8,030 New
8,030 $4.31 Million
Q1 2023

Feb 22, 2024

SELL
$310.63 - $364.82 $1.53 Million - $1.8 Million
-4,926 Reduced 82.33%
1,057 $362,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $196,628 - $230,931
-633 Reduced 22.08%
2,234 $767,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $921,883 - $1.07 Million
2,867 New
2,867 $1.05 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $1.95 Million - $2.29 Million
7,005 New
7,005 $2.27 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $2.07 Million - $2.57 Million
-8,814 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.98 Million - $2.46 Million
8,814 New
8,814 $2.44 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $652,168 - $802,585
-2,943 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $531,358 - $687,308
2,943 New
2,943 $675,000
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $332,020 - $439,343
-2,545 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $372,129 - $430,435
2,545 New
2,545 $377,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $454,391 - $494,260
-4,255 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $471,411 - $550,256
4,255 New
4,255 $471,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $3.06 Million - $3.43 Million
-28,934 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $779,179 - $973,838
-9,075 Reduced 23.88%
28,934 $3.11 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $2.88 Million - $3.3 Million
38,009 New
38,009 $3.24 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.